Global Study of Del-desiran for the Treatment of DM1

Clinical trial NCT06411288 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06411288
Sponsor: Avidity Biosciences, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

DM1 Myotonic Dystrophy Myotonic Dystrophy 1 Myotonia Myotonic Dystrophy Type 1 (DM1)Dystrophy Myotonic Myotonic Disorders Steinert Disease Steinert Myotonic Muscular Dystrophy

Start date: 2024-05-30
Primary completion: 2026-08-01
Enrollment: 159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.